HealthQuill - HealthQuill

Stem cell therapies, which replace dead cells in the brain, can stop movement problems, rigidity and tremors in patients, two small trial studies show.

Stem cell therapy revives hope for patients with Parkinson’s disease

HQ Team April 17, 2025: Stem cell therapies, which replace dead cells in the brain, can stop movement problems, rigidity and tremors in

by HealthQuill
April 17, 2025
0 Comments

Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving civilians of shelter, food and medicine, the UN warns.

Drugs Health Medical

Dire humanitarian crisis engulfs Gaza Strip, displaced people swell: UN

HQ Team April 17, 2025: Escalating hostilities and limited access to medical supplies are exacerbating an already dire humanitarian crisis in Gaza depriving

by HealthQuill
April 17, 2025
0 Comments

Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate of worsening episodes in adults with moderate-to-severe asthma, according to a statement.

Drugs Health Pharma

Sanofi’s test drug to treat moderate-to-severe asthma fails to meet goals

HQ Team April 17, 2025: Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate

by HealthQuill
April 17, 2025
0 Comments

Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations of the US-based company’s peptides for an upfront payment of $493 million.

Drugs Health Medical

Austria’s Cyprumed in $493 million pact with Merck to develop peptides

HQ Team April 17, 2025: Austria’s Cyprumed GmbH has announced a license and option agreement with Merck & Co., to develop oral formulations

by HealthQuill
April 17, 2025
0 Comments

An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted infections in the world, according to the results of an end-stage study published in The Lancet.

Drugs Health Research

Oral antibiotic shows efficacy in end-stage trials to treat gonorrhoea

HQ Team April 16, 2025: An oral antibiotic, gepotidacin, has shown efficacy in fighting gonorrhoea — one of the most prevalent sexually transmitted

by HealthQuill
April 16, 2025
0 Comments

Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union, according to a joint statement from the companies.

Drugs Health Pharma

Eisai Co, Biogen Inc.’s Alzheimer’s drug gets EU’s marketing approval

HQ Team April 16, 2025: Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union,

by HealthQuill
April 16, 2025
0 Comments

The 194 Member States of the WHO have reached a consensus on a draft agreement to strengthen global collaboration on prevention, preparedness and response to future pandemic threats.

Drugs Health Pharma

WHO’s Pandemic Agreement reaches consensus, may be adopted in May

HQ Team April 16, 2025: The 194 Member States of the WHO have reached a consensus on a draft agreement to strengthen global

by HealthQuill
April 16, 2025
0 Comments

Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that processes visual information.

Drugs Health Pharma

Stanford researchers build ‘digital twin’ of a part of mouse brain

HQ Team April 15, 2025: Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that

by HealthQuill
April 15, 2025
0 Comments

Harvard University has rejected demands from US President Donald Trump’s administration that threaten $9 billion in research funding.

Drugs Health Pharma

Harvard rejects Trump’s demands that threaten $9b research funding

HQ Team April 15, 2025: Harvard University has rejected demands from US President Donald Trump’s administration that threaten $9 billion in research funding.